Gene · 28882
Papers3,857
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,857
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Estimating fine age structure and time trends in human contact patterns from coarse contact data: The Bayesian rate consistency model. | PLoS Comput Biol | 2023 | 37276210 | PubTator, text mining | PubMed |
| The olfactory Olfr-78/51E2 receptor interacts with the adenosine A2A receptor. Effect of menthol and 1,8-cineole on A2A receptor-mediated signaling. | Front Pharmacol | 2023 | 37266149 | PubTator, text mining | PubMed |
| Crystal structure of adenosine A2A receptor in complex with clinical candidate Etrumadenant reveals unprecedented antagonist interaction. | Commun Chem | 2023 | 37264098 | PubTator, text mining | PubMed |
| The CD73 immune checkpoint promotes tumor cell metabolic fitness. | Elife | 2023 | 37261423 | PubTator, text mining | PubMed |
| "Dual Anta-Inhibitors" of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies. | Pharmaceuticals (Basel) | 2023 | 37259317 | PubTator, text mining | PubMed |
| The detailed classification of the interlobar artery and the artery crossing intersegmental planes in the right upper lobe. | Front Oncol | 2023 | 37256176 | PubTator, text mining | PubMed |
| The inhibitory receptors PD1, Tim3, and A2aR are highly expressed during mesoCAR T cell manufacturing in advanced human epithelial ovarian cancer. | Cancer Cell Int | 2023 | 37244991 | PubTator, text mining | PubMed |
| Mesenchymal Stromal Cell Exosomes Mediate M2-like Macrophage Polarization through CD73/Ecto-5'-Nucleotidase Activity. | Pharmaceutics | 2023 | 37242732 | PubTator, text mining | PubMed |
| Synergistic Effects of Caffeine in Combination with Conventional Drugs: Perspectives of a Drug That Never Ages. | Pharmaceuticals (Basel) | 2023 | 37242514 | PubTator, text mining | PubMed |
| Targeting Immunosuppressive Adenosine Signaling: A Review of Potential Immunotherapy Combination Strategies. | Int J Mol Sci | 2023 | 37240219 | PubTator, text mining | PubMed |
| Distribution of α2-Adrenergic Receptors in the Living Human Brain Using [11C]yohimbine PET. | Biomolecules | 2023 | 37238713 | PubTator, text mining | PubMed |
| Adult attention deficit hyperactivity disorder: a comprehensive review. | Ann Med Surg (Lond) | 2023 | 37228994 | PubTator, text mining | PubMed |
| Generative Models Should at Least Be Able to Design Molecules That Dock Well: A New Benchmark. | J Chem Inf Model | 2023 | 37224003 | PubTator, text mining | PubMed |
| Dexmedetomidine as an Adjuvant in Peripheral Nerve Block. | Drug Des Devel Ther | 2023 | 37220544 | PubTator, text mining | PubMed |
| Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint Inhibitors. | J Immunother Precis Oncol | 2023 | 37214204 | PubTator, text mining | PubMed |
| The indirect pathway of the basal ganglia promotes transient punishment but not motor suppression. | Neuron | 2023 | 37207651 | PubTator, text mining | PubMed |
| Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppression. | J Natl Cancer Inst | 2023 | 37195421 | PubTator, text mining | PubMed |
| Electromagnetic fields regulate calcium-mediated cell fate of stem cells: osteogenesis, chondrogenesis and apoptosis. | Stem Cell Res Ther | 2023 | 37194107 | PubTator, text mining | PubMed |
| Parsimonious Effect of Pentoxifylline on Angiogenesis: A Novel Pentoxifylline-Biased Adenosine G Protein-Coupled Receptor Signaling Platform. | Cells | 2023 | 37190108 | PubTator, text mining | PubMed |
| Mast Cells as a Target-A Comprehensive Review of Recent Therapeutic Approaches. | Cells | 2023 | 37190096 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28882/papers?page=14